Fill out the form below to contact us today. A representative of our firm will be in touch with you shortly.
Studies have shown that Avandia®may increase the risk of the following conditions:
On May 21, 2007, the U.S. Food and Drug Administration issued a formal safety alert regarding the potential increased risk of heart attack and heart-related death caused by Avandia® use. The warning was prompted by a review of studies, conducted by cardiologist Steven Nissen of the Cleveland Clinic, in which it was found that Avandia® significantly increased the risks of heart attack. Though Nissen's conclusions remain under review, the FDA has warned that "these data, if confirmed, would be of significant concern since patients with diabetes are already at an increased risk of heart disease." For more information about the potential risks of Avandia®, see our Avandia® side effects page.
Patients and physicians should weigh the benefits and risks of treatment with Avandia®. Glycemic control and durability appear to be the major benefits. Avandia® is also associated with significant weight gain, an adverse effect on low-density lipoprotein cholesterol, an increased risk of heart failure, an increased risk of bone fractures in women, and an apparent increase in the risk of myocardial infarction. Patients should not stop treatment on their own, but if they have concerns, they should consult their physicians. Together, patients and physicians can decide whether they wish to suspend the use of Avandia®.
There is a wealth of information available online, including on this website, that can help you determine if you have a case. The best way for you to find out, however, if you have a claim is to speak directly with an experienced attorney. To arrange a free consultation with one of our Avandia® lawyers, please contact us today.
Yes, lawsuits have been and are being filed around the country that accuse GlaxoSmithKline, the maker of Avandia®, of failing to disclose pertinent information related to the potential dangers of Avandia. For example, in one case, filed May 29 in U.S. District Court for the Eastern District of Louisiana, Sharon Ann Dagon claims Avandia® caused her to suffer "one or more of the following kinds of damage:" myocardial infarction, heart injury, excessive fluid retention, fluid-overload disease, liver damage and liver failure. The suit alleges Glaxo didn't properly warn consumers about the risks of Avandia®.
In another federal case, filed June 1 in the Southern District of New York, plaintiff Benjamin Marconi said he suffered a heart attack and congestive heart failure after taking Avandia®. The suit alleges GlaxoSmithKline omitted or misrepresented key safety data about the drug.
If you or someone you love has been injured as a result of using Avandia®, contact the personal injury attorneys at Phillips & Associates today. We will work to recover compensation for lost wages, medical expenses, pain and suffering, and other applicable damages.